share_log

Virpax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Jambulingam Thani

Virpax制药 | 4:持股变动声明-董事 Jambulingam Thani

美股SEC公告 ·  01/31 16:29

Moomoo AI 已提取核心信息

Jambulingam Thani, associated with Virpax Pharmaceuticals Inc. [VRPX], was involved in a transaction on January 29, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The relationship of Jambulingam Thani to the issuer was not specified, and there was no information provided regarding the number of shares held after the action.
Jambulingam Thani, associated with Virpax Pharmaceuticals Inc. [VRPX], was involved in a transaction on January 29, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The relationship of Jambulingam Thani to the issuer was not specified, and there was no information provided regarding the number of shares held after the action.
与 Virpax Pharmicals Inc. [VRPX] 关联的 Jambulingam Thani 于 2024 年 1 月 29 日参与了一笔交易。公告中未披露该交易的具体细节,包括股票数量、股票性质、交易价格和股票总价值。没有具体说明Jambulingam Thani与发行人的关系,也没有提供有关诉讼后持有的股票数量的信息。
与 Virpax Pharmicals Inc. [VRPX] 关联的 Jambulingam Thani 于 2024 年 1 月 29 日参与了一笔交易。公告中未披露该交易的具体细节,包括股票数量、股票性质、交易价格和股票总价值。没有具体说明Jambulingam Thani与发行人的关系,也没有提供有关诉讼后持有的股票数量的信息。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息